Navigation Links
AHIP Statement on National Health Expenditure Data
Date:1/6/2009

Health insurance premiums remain stable

WASHINGTON, Jan. 6 /PRNewswire-USNewswire/ -- Karen Ignagni, President and CEO of America's Health Insurance Plans, issued a statement on new data released by CMS today showing that health spending in the United States grew at the lowest rate in a decade at 6.1 percent in 2007.

According to the CMS report, private health insurance premiums grew 6.0 percent in 2007, the same rate as in 2006, but much lower than the recent peak of 10.7 percent in 2002. CMS also found that health plans' administrative costs were 12.2 percent in 2007, less than the 12.8 percent in 2006.

"Health plans have implemented innovative programs to reduce the rate of growth of health care costs, improve health care quality, and streamline administrative processes," said Ignagni. "Today's report confirms that health insurance premiums reflect the underlying cost of medical care."

"While substantial progress is being made, much more work needs to be done to put health care spending on a sustainable path and to ensure that every American has affordable health care coverage. As Congress pursues health care reform, reducing the rate of growth of health care costs must be a top priority," said Ignagni.

AHIP's Board of Directors has put forth a comprehensive reform proposal to cover all Americans, improve quality, and contain costs. This proposal urges Congress to set a national target of reducing the future growth of health care costs by 30 percent and to establish an independent advisory board to provide a road map on how to achieve these cost reductions.

To learn more about this proposal and AHIP's efforts to advance health care reform, visit www.AmericanHealthSolution.org.

Providing Health Benefits for Over 200 Million Americans.


'/>"/>
SOURCE America's Health Insurance Plans
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Statement from Melissa Murer Corrigan, RPh, Executive Director and CEO of Pharmacy Technician Certification Board (PTCB)
2. ESC statement on the control of type 2 diabetes
3. AAHSA Statement on CMS Five-Star Rating System for Nursing Homes
4. An ESC statement on gender differences in medical care and survival after myocardial infarction
5. AMERIGROUP Files Shelf Registration Statement
6. American Academy of Dermatology Issues Statement on FDA Report to Congress About Labeling Information on Indoor Tanning Devices
7. CU Statement on FDA Position on Mercury From Fish Consumption
8. Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administrations Reversal on Antibiotics Safeguards in Animal Farming
9. Statement of Peter H. Cressy, President, Distilled Spirits Council, Regarding the Monitoring the Future Survey on Underage Drinking
10. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
11. Catholic Health Association Statement on the Naming of Tom Daschle and Jeanne Lambrew to Health Leadership Positions in President-Elect Obamas Administration

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sentine...anceImaging(MRI)coilsandsoftwareandCalgaryScientif...ies,haveintroducedawebversionofAegis(TM)Breast4DAd...nterfaceisthefirsttrulyzero-footprintWebclientbase...ic,sPureWeb(TM)platformallowsforzero-footprintacce...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswir...,sCenterforDrugEvaluationandResearch,titled"ADiffi...ppearsintheNov.26,2009issueofTheNewEnglandJournalo...-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,Wo...cesstopainmedicationforthosewhoneeditandmanagingth...
(Date:11/25/2009)...,, BroadPoliticalEndorsements,Business,andPres...RNewswire-USNewswire/--Onceagain,theNationalBipola...amationendorsingtheir"Safe,tilStable"program,which...sureforbipolardisorder.Today,theNationalBipolarFou...lExpressPriorityMailfromtheLt.GovernorofLouisianaM...
(Date:11/25/2009)... A fortuitous discovery that grew out of a collab...d potentially offer hope to the nearly 10 million ...ase. , Also known as hardening of the arteri...on circulatory problem in which narrowed arteries ...onsidered a red flag for vascular disease, heart a...
(Date:11/25/2009)...tuximab, already used to fight rheumatoid arthriti...ds , , WEDNESDAY, Nov. 25 (HealthDay New...lymphoma and rheumatoid arthritis now also shows s...th type 1 diabetes. , The drug, rituximab (Ritu... own insulin, even though the disease had destroye...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...t it is all over between Kate Moss and Pete Dohert...ican model , it seems that the waifish beauty will...implant. The implant will be the fifth one... she understands that Doherty needs help and will ...
...ammed Haneef, the man from Bangalore in southern I...avy price for a small act of indiscretion, it look...his cousins, the key players in the failed Glasgow...ly to crash. First Australian authorities alm...
...that more than 90 per cent of women undergoing fer...f fertility drugs meant to stimulate their ovaries...ans that the drugs may not work properly, but also...however increased during IVF, by giving them drugs...
...ol of Public Health (HSPH) shows that patients who...ic quality measures have a lower chance of dying ... The researchers calculate that if the lowest p... surveyed hospitals from acute myocardial infarcti...
...ess' has been named the most vegan-friendly food c...d by the animal rights group for its cheese-free p...is one of the 20 organisations recognised by PETA ...London with a pizza oven and chef imported from It...
...started walking on two legs is something yet to be...sized that bipedalism evolved as a way of reducin... study to fully examine this theory among humans a...ll trials to analyze walking energetics and biomec...
Other Medicine News:Health News:Haneefs Visa Revoked by Australia 2Health News:Lower Mortality Rates in Hospitals With Good Quality Care 2
(Date:11/25/2009)...Nov.25/PRNewswire/--CempraPharmaceuticalsInc.today...fexecutiveofficer,willpresentatthePiperJaffray21st...2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Ferna...ntibioticclinicalprogramsforthetreatmentofdrug-res...armaceuticals ,, Foundedin2006,CempraPharmaceu...
(Date:11/25/2009)...if.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announ...sPROTECT-1(theProspectiveRandomizedOralTherapyEval...82-B)inpatientswithmoderate-to-severeCrohn,sdiseas...ndtolerabilityprofile.Thestudydemonstratedevidence...sdefinedasa70-pointdecreaseintheCrohn,sDiseaseActi...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 1Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 2Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 4Ultimat Vodka Joins Fight Against Hunger 61545 1Ultimat Vodka Joins Fight Against Hunger 61545 2Shopko Announces Launch of e Commerce Platform 61542 1Shopko Announces Launch of e Commerce Platform 61542 2
...HAYWARD, Calif., Aug. 6 Kosan Biosciences,Incorpo... Inc. has initiated,a Phase 1 clinical trial of mo...187, a selective and potent motilin receptor agoni...hageal reflux disease (GERD) and potentially,other...ical trial is,designed to test the safety, tolerab...
...SAN DIEGO, Aug. 7 Vical Incorporated (Nasdaq:,VIC...r ended June 30, 2007.,Revenues for the second qua...nues of $7.3 million for the second quarter of 200... $8.2 million, or $0.21 per share, compared,with a... the second quarter,of 2006. The increase in net l...
Other Medicine Technology:Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 2Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 3Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6
Jeweler Type Bipolar Insulated Forceps
Robb Tonsil Knife
Canfield Tonsil Knife
Converse Button End Bistoury
Medicine Products: